Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05014165

Backtracking Leukemia-Typical Somatic Mutations in Cord Blood

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Children's Oncology Group · Network
Sex
All
Age
25 Years
Healthy volunteers
Not accepted

Summary

A comprehensive mechanistic and epidemiological study to obtain banked cord blood samples from consecutive childhood leukemia patients enrolled in the COG Project:EveryChild (APEC14B1) study. Will attempt to backtrack the initiating genomic alteration identified in the matched diagnostic leukemia sample and molecularly characterize pre-leukemic cells. The ultimate goal of this research is to pinpoint the cell of origin of leukemogenic alterations formed in utero, elucidating the etiology of these initiating mutations (as opposed to frank leukemia), and devising a test for circulating pre-leukemia that can be applied on a population-wide basis.

Detailed description

OBJECTIVES: Primary Aim 1: To obtain stored cord blood and dried bloodspots of pediatric leukemia patients in Project:EveryChild. Secondary Aim 2: To conduct preliminary backtracking and characterization of ALL- and AML-typical somatic mutations in cord blood and dried bloodspots. OUTLINE: Accrue patients with ALL and AML who indicate having banked cord blood at birth through the APEC14B1 intake questionnaire

Conditions

Interventions

TypeNameDescription
OTHERCord blood Sample CollectionObtain banked cord blood samples from consecutive childhood leukemia patients
OTHERCase identification and recruitmentCases meeting eligibility and who have given consent through APEC14B1 for future contact for non-therapeutic studies
OTHERQuestionnaire AdministrationThe family will be given an option to complete questionnaire on paper, online, or over the telephone.

Timeline

Start date
2021-08-25
Primary completion
2026-09-30
Completion
2026-09-30
First posted
2021-08-20
Last updated
2026-04-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05014165. Inclusion in this directory is not an endorsement.